000 01592 a2200445 4500
005 20250517205554.0
264 0 _c20190819
008 201908s 0 0 eng d
022 _a1179-1896
024 7 _a10.1007/s40258-018-0384-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLim, Ka Keat
245 0 0 _aIs BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia.
_h[electronic resource]
260 _bApplied health economics and health policy
_c06 2018
300 _a395-406 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBreast Neoplasms
_xdiagnosis
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDeveloped Countries
650 0 4 _aEarly Detection of Cancer
650 0 4 _aFemale
650 0 4 _aGenes, BRCA1
650 0 4 _aGenetic Testing
_xeconomics
650 0 4 _aHumans
650 0 4 _aLikelihood Functions
650 0 4 _aMarkov Chains
650 0 4 _aMutation
_xgenetics
650 0 4 _aQuality-Adjusted Life Years
650 0 4 _aSensitivity and Specificity
700 1 _aYoon, Sook Yee
700 1 _aMohd Taib, Nur Aishah
700 1 _aShabaruddin, Fatiha Hana
700 1 _aDahlui, Maznah
700 1 _aWoo, Yin Ling
700 1 _aThong, Meow Keong
700 1 _aTeo, Soo Hwang
700 1 _aChaiyakunapruk, Nathorn
773 0 _tApplied health economics and health policy
_gvol. 16
_gno. 3
_gp. 395-406
856 4 0 _uhttps://doi.org/10.1007/s40258-018-0384-8
_zAvailable from publisher's website
999 _c28211727
_d28211727